Records containing: Pheochromocytoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-07-05Cone-beam Computed Tomography Guided Percutaneous Cryoablation of Bone Metastases From Endocrine Tumors
-
CLINICAL_TRIALS study record update · 2023-06-01A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of Pheochromocytoma or Paraganglioma Patients
-
CLINICAL_TRIALS study record update · 2023-05-31A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of Locally Advanced, or Unresectable Pheochromocytoma or Paraganglioma
-
CLINICAL_TRIALS study record update · 2023-04-07Development of a Comprehensive Predictive Model for Risk of Metastatic Disease in PPGLs Based on a Combination of Clinical, Biochemical, Genetic, and Pathoanatomical Characteristics a Retrospective National Cohort Study
-
CLINICAL_TRIALS study record update · 2023-03-10A Phase II, Non-Randomized, Open-Label, Single-center, Physician Sponsored Study to Determine the Safety and Effectiveness of Lu-177 DOTATOC in Adult Subjects With Somatostatin Receptor Expressing Pulmonary, Pheochromocytoma, paragangliomUnknown Primary, and Thymus Neuroendocrine Tumors (PUTNET) or Any Other Non-.GEP-NET.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-28An Open Label, Expanded Access Protocol Using 131I-metaiodobenzylguanidine (131I-MIBG) Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma (Not Eligible for Approved Treatment)
-
CLINICAL_TRIALS study record update · 2023-02-21[18 F]-6-L-fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET) in Neuroendocrine Tumours
-
CLINICAL_TRIALS study record update · 2022-07-12Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
-
CLINICAL_TRIALS study record update · 2022-05-23Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue
-
CLINICAL_TRIALS study record update · 2022-02-14China Adrenal Disease Registry Study
-
CLINICAL_TRIALS study record update · 2022-02-10Prospective Cohort Study of Objective Cardiac and Vascular Changes in Pheochromocytoma and Paraganglioma and Their Reversal Following Curative Surgery
-
CLINICAL_TRIALS study record update · 2022-01-19Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma
-
CLINICAL_TRIALS study record update · 2021-09-01The Perioperative Use of Dexmedetomidine and Magnesium Sulfate Compared With Traditional Anesthetic Technique for Open Resection of Pheochromocytoma.
-
CLINICAL_TRIALS study record update · 2021-06-18Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis
-
CLINICAL_TRIALS study record update · 2021-06-08Phase I Trial of Peptide Receptor Radiotherapy (PRRT) With 177Lu-DOTA-tyr3-Octreotate (177Lu-DOTATATE) in Children and Adolescents With Neuroendocrine Tumor or Pheochromocytoma/Paraganglioma
-
CLINICAL_TRIALS study record update · 2021-05-18Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
-
CLINICAL_TRIALS study record update · 2021-05-10A Phase II Trial of the DNA Methyl Transferase Inhibitor, SGI-110 (Guadecitabine), In Children And Adults With Wild Type GIST, Pheochromocytoma And Paraganglioma Associated With Succinate Dehydrogenase Deficiency And HLRCC-Associated Kidney Cancer
-
CLINICAL_TRIALS study record update · 2020-09-28Risk Factors for Hemodynamic Instability During Laparoscopic Pheochromocytoma Resection - Single Centre Experience
-
CLINICAL_TRIALS study record update · 2020-08-31Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
-
CLINICAL_TRIALS study record update · 2020-07-09The MUPPET-study: Multicenter Pheochromocytoma and Paraganglioma Evaluation for Follow-up Screening, Genetics Sub-Typing, Therapy and Outcome
-
CLINICAL_TRIALS study record update · 2020-05-06Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma
-
CLINICAL_TRIALS study record update · 2020-03-18A Prospective Cohort Study for Patients With Adrenal Diseases
-
CLINICAL_TRIALS study record update · 2019-08-28Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions on Cross-sectional Imaging (CT or MRI)
-
CLINICAL_TRIALS study record update · 2019-05-31An Open-Label, Multicentre, Phase 3 Scintigraphy Study Assessing 123I-mIBG Uptake in Subjects Being Evaluated for Phaeochromocytoma or Neuroblastoma
-
CLINICAL_TRIALS study record update · 2019-01-30Expanded Access Program of AZEDRA (Ultratrace Iobenguane I131) in Subjects With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma: A Sub-study of Protocol MIP-IB12B